Because TREX1 is known to play a crucial role in regulating the innate immune response, these data suggest that TREX1 induction may be a mechanism for SCLC cells to adapt and survive the inflammation associated with DNA-damaging drug treatments such as chemotherapy. This evidence concerns the gene TREX1 and small cell lung carcinoma.